- Home
- ESLA vs NIXX Comparison
ESLA vs NIXX Comparison
Compare ESLA & NIXX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ESLA
- NIXX
- Stock Information
- Founded
- ESLA 2021
- NIXX 2010
- Country
- ESLA United States
- NIXX United States
- Employees
- ESLA N/A
- NIXX N/A
- Industry
- ESLA Biotechnology: Biological Products (No Diagnostic Substances)
- NIXX
- Sector
- ESLA Health Care
- NIXX
- Exchange
- ESLA Nasdaq
- NIXX NYSE
- Market Cap
- ESLA 35.5M
- NIXX 39.8M
- IPO Year
- ESLA N/A
- NIXX N/A
- Fundamental
- Price
- ESLA $0.94
- NIXX $1.78
- Analyst Decision
- ESLA Strong Buy
- NIXX
- Analyst Count
- ESLA 1
- NIXX 0
- Target Price
- ESLA $16.00
- NIXX N/A
- AVG Volume (30 Days)
- ESLA 521.4K
- NIXX 255.3K
- Earning Date
- ESLA 08-20-2025
- NIXX 08-13-2025
- Dividend Yield
- ESLA N/A
- NIXX N/A
- EPS Growth
- ESLA N/A
- NIXX N/A
- EPS
- ESLA N/A
- NIXX N/A
- Revenue
- ESLA N/A
- NIXX $1,786,387.00
- Revenue This Year
- ESLA $101.09
- NIXX N/A
- Revenue Next Year
- ESLA N/A
- NIXX N/A
- P/E Ratio
- ESLA N/A
- NIXX N/A
- Revenue Growth
- ESLA N/A
- NIXX 54.16
- 52 Week Low
- ESLA $0.63
- NIXX $1.35
- 52 Week High
- ESLA $3.23
- NIXX $8.50
- Technical
- Relative Strength Index (RSI)
- ESLA 46.99
- NIXX N/A
- Support Level
- ESLA $0.89
- NIXX N/A
- Resistance Level
- ESLA $1.02
- NIXX N/A
- Average True Range (ATR)
- ESLA 0.09
- NIXX 0.00
- MACD
- ESLA -0.00
- NIXX 0.00
- Stochastic Oscillator
- ESLA 21.16
- NIXX 0.00
About ESLA Estrella Immunopharma Inc.
Estrella Immunopharma Inc is a clinical-stage biopharmaceutical company developing CD19 and CD22-targeted ARTEMIS T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors. Estrella's mission is to harness the evolutionary power of the human immune system to transform the lives of patients fighting cancer and autoimmune diseases.
About NIXX NIXXY INC
Nixxy Inc is a hiring platform for the network of recruiters. It empowers businesses to recruit specialized talent faster with virtual teams of recruiters and AI job-matching technology.Recently, the Company acquired the license from GoLogiq, Inc. (GoLogiq), to operate its fintech technology (the GOLQ Technology) and sell products derived thereof, including its Createapp, Paylogiq, Gologiq, and Radix AI technology and products.. Its Recruiters On Demand provides businesses of all sizes access to virtual recruiters specialized by vertical industries to source, engage, and hire talent on an as-needed basis.